Commission Regulation (EC) No 1096/2008 of 6 November 2008 amending Regulation (EC) No 1356/2004 as regards the terms of the authorisation of the feed additive Elancoban , belonging to the group of coccidiostats and other medicinal substances (Text with EEA relevance)

• CELEX: Regulation (EC) No 1096/2008
• Articles: 3

Article 1

The Annex to Regulation (EC) No 1356/2004 is replaced by the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Registration number of additive

Name and registration number of person responsible for putting additive into circulation

Additive

(Trade name)

Composition, chemical formula, description

Species or category of animal

Maximum age

Minimum content

Maximum content

Other provisions

End of period of authorisation

Provisional maximum residue limits (MRLs) in the relevant foodstuffs of animal origin

mg of active substance/kg of complete feedingstuff

Coccidiostats and other medicinal substances

E 757

Eli Lilly and Company Limited

Monensin sodium

(Elancoban G100, Elancoban 100, Elancogran 100, Elancoban G200, Elancoban 200)

Active substance

C 36 H 61 O 11 Na

sodium salt of polyether monocarboxylic acid produced by Streptomyces cinnamonensis , ATCC 15413 in granular form.

Factor composition:

Monensin A: not less than 90 %

Monensin A + B: not less than 95 %

Additive composition

Granular monensin (dried fermentation product) equivalent to Monensin activity 10 % w/w

Mineral oil 1-3 % w/w

Limestone granular 13-23 % w/w

Rice hulls or limestone granular qs 100 % w/w

Granular monensin (dried fermentation product) equivalent to Monensin activity 20 % w/w

Mineral oil 1-3 % w/w

Rice hulls or limestone granular qs 100 % w/w

Chickens for fattening

—

100

125

Use prohibited at least one day before slaughter.

Indicate in the instructions for use:

‘Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances’

30.7.2014

25 μg/kg monensin sodium of wet skin + fat

8 μg/kg monensin sodium of wet liver, wet kidney and wet muscle.

Chickens reared for laying

16 weeks

100

120

Turkeys

16 weeks

60

100